Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls:: Concomitant assessment of perforin, IFN-γ and IL-4 secretion

被引:12
作者
Burton, CT [1 ]
Gotch, F [1 ]
Imami, N [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London SW10 9NH, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
lymphocyte responses; highly active antiretroviral therapy (HAART); interferon gamma; perforin; interleukin-4; T-cell memory; T-cell anergy;
D O I
10.1016/j.jim.2005.11.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme-linked inummospot (ELIspot) assay is a highly sensitive and valuable tool for determining the frequency of cytokine-secreting T cells. It is essential to determine both frequencies and functional capabilities of antigen-specific T cells, including cytokine secretion, degranulation, and cytotoxicity in order to obtain a faller picture of the immune status of an individual. We describe here for the first time a perforin-release ELIspot assay which, when used in combination with IFN-gamma and IL-4 ELIspots, permits rapid assessment of these functional parameters for antigen-specific T cells. Whole antigen or peptides from HIV-1, recall and other viral antigens were used for in vitro stimulation. Anti-HIV-1 responses in treated chronically infected individuals were weak, both in terms of perform and IFN-gamma production. Tetanus toxoid stimulation was associated with moderate perforin release and a predominantly type-2 IL-4 producing response, whilst herpes simplex virus antigen stimulation resulted in perforin release but only a weak type-1 IFN-gamma response. Anti-cytomegalovirus responses generated high levels of perform in conjunction with IFN-gamma. Cytokines IL-2 and IL-12/IL-15 induced perform release coupled with an IFN-gamma type-1 response. Perform release strongly correlated with IFN-gamma production to individual influenza, Epstein-Barr virus or cytomegalovirus MHC class I restricted peptides, in an HIV-1 sero-negative cohort, indicating a cytolytic type-1 CD8(+) T-cell response. Evaluation of immunogenicity and putative efficacy of candidate vaccines using IFN-gamma will not be as informative alone as when combined with perforin and IL-4 evaluations, which allow assessment of specific cytotoxic potential without extensive cell culture. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:216 / 230
页数:15
相关论文
共 34 条
  • [11] Vaccination in humans generates broad T cell cytokine responses
    De Rosa, SC
    Lu, FX
    Yu, J
    Perfetto, SP
    Falloon, J
    Moser, S
    Evans, TG
    Koup, R
    Miller, CJ
    Roederer, M
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (09) : 5372 - 5380
  • [12] HIV preferentially infects HIV-specific CD4+ T cells
    Douek, DC
    Brenchley, JM
    Betts, MR
    Ambrozak, DR
    Hill, BJ
    Okamoto, Y
    Casazza, JP
    Kuruppu, J
    Kuntsman, K
    Wolinsky, S
    Grossman, Z
    Dybul, M
    Oxenius, A
    Price, DA
    Connors, M
    Koup, RA
    [J]. NATURE, 2002, 417 (6884) : 95 - 98
  • [13] Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection
    Draenert, R
    Verrill, CL
    Tang, Y
    Allen, TM
    Wurcel, AG
    Boczanowski, M
    Lechner, A
    Kim, AY
    Suscovich, T
    Brown, NV
    Addo, MM
    Walker, BD
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (02) : 630 - 641
  • [14] Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors
    Gea-Banacloche, JC
    Migueles, SA
    Martino, L
    Shupert, WL
    McNeil, AC
    Sabbaghian, MS
    Ehler, L
    Prussin, C
    Stevens, R
    Lambert, L
    Altman, J
    Hallahan, CW
    de Quiros, JCLB
    Connors, M
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (02) : 1082 - 1092
  • [15] Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence
    Harari, A
    Vallelian, F
    Meylan, PR
    Pantaleo, G
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (02) : 1037 - 1045
  • [16] Cytomegalovirus (CMV)-specific cellular immune responses
    Harari, A
    Zimmerli, SC
    Pantaleo, G
    [J]. HUMAN IMMUNOLOGY, 2004, 65 (05) : 500 - 506
  • [17] Harto MA, 1996, J REFRACT SURG, V12, P585
  • [18] A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection
    Imami, N
    Pires, A
    Hardy, G
    Wilson, J
    Gazzard, B
    Gotch, F
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (18) : 9011 - 9023
  • [19] Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination
    Imami, N
    Hardy, G
    Burton, C
    Pires, A
    Pido-Lopez, J
    Moss, R
    Gazzard, B
    Gotch, F
    [J]. IMMUNOLOGY LETTERS, 2001, 79 (1-2) : 63 - 76
  • [20] Imami N, 1999, CLIN EXP IMMUNOL, V118, P78